Hormone receptor mRNA and protein levels as predictors of premenopausal tamoxifen benefit

Hormone receptor mRNA and protein levels as predictors of premenopausal tamoxifen benefit

ABSTRACT Background and purpose: Tamoxifen remains an important adjuvant treatment in premenopausal patients with hormone receptor-positive breast cancer. Thus, determination of hormone receptors is important. Here, we compare cytosol-based methods, immunohistochemistry (IHC), and gene expression (...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Terese Engström, Maria Ekholm, Mårten Fernö, Christine Lundgren, Bo Nordenskjöld, Olle Stål, Pär-Ola Bendahl, Julia Tutzauer, Lisa Rydén
Formatua: Artikulua
Hizkuntza:English
Argitaratua: Medical Journals Sweden 2024-04-01
Saila:Acta Oncologica
Gaiak:
breast cancer
tamoxifen
premenopausal patients
randomized trial
estrogen receptor status
progesterone receptor status
Sarrera elektronikoa:https://medicaljournalssweden.se/actaoncologica/article/view/19655

Internet

https://medicaljournalssweden.se/actaoncologica/article/view/19655

Antzeko izenburuak